Junyou Ge
Impact in
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 3
- HER2/EGFR in Cancer Research 2
- Cancer Treatment and Pharmacology 1
- Cancer Immunotherapy and Biomarkers 1
-
- Cell Adhesion Molecules Research 1
- Co-authors
- Qing Yan (3 shared papers)Xichun Hu (1 shared paper)Ying Wang (2 shared papers)Rujiao Liu (1 shared paper)Shuiping Gao (1 shared paper)Jian Zhang (1 shared paper)Wenhua Li (1 shared paper)Yanrong Hao (1 shared paper)
- Journals
- BMJ (1 paper)Nature Medicine (1 paper)Oral Oncology (1 paper)Expert Opinion on Investigational Drugs (1 paper)Advances in Therapy (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Junyou Ge
5 papers receiving 94 citations
Junyou Ge's Hit Papers
Peers
Comparison fields: 5 of 18
- Oncology 55
- Radiology, Nuclear Medicine and Imaging 25
- Pulmonary and Respiratory Medicine 21
- Otorhinolaryngology 2
- Genetics 3
Countries citing papers authored by Junyou Ge
This map shows the geographic impact of Junyou Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyou Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyou Ge more than expected).
Fields of papers citing papers by Junyou Ge
This network shows the impact of papers produced by Junyou Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyou Ge. The network helps show where Junyou Ge may publish in the future.
Co-authors
The 25 scholars most cited alongside Junyou Ge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 47 | |
| 2 | Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial Hit paper breakdown → | 2025 | 28 |
| 3 | 2025 | 17 | |
| 4 | 2024 | 3 | |
| 5 | 2025 | 3 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 0 | |
| 8 | 2025 | 0 |
About Junyou Ge
Junyou Ge is a scholar working on Oncology, Immunology and Allergy, Pulmonary and Respiratory Medicine, Rheumatology and Radiology, Nuclear Medicine and Imaging, having authored 8 papers that have together received 98 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (2 papers), Cell Adhesion Molecules Research (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Cancer Treatment and Pharmacology (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper), Advanced Breast Cancer Therapies (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Oncology (55 citations), Radiology, Nuclear Medicine and Imaging (25 citations), Pulmonary and Respiratory Medicine (21 citations), Otorhinolaryngology (2 citations) and Genetics (3 citations). Junyou Ge has collaborated with scholars based in China and United States. Frequent co-authors include Qing Yan, Xichun Hu, Ying Wang, Rujiao Liu, Shuiping Gao, Jian Zhang, Wenhua Li, Yanrong Hao, Yang Chen and Chang Liu. Their work appears in journals such as BMJ, Nature Medicine, Oral Oncology, Expert Opinion on Investigational Drugs and Advances in Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.